MANFREDI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 47
NA - Nord America 37
AS - Asia 24
Totale 108
Nazione #
US - Stati Uniti d'America 36
IT - Italia 25
SE - Svezia 19
CN - Cina 8
SG - Singapore 6
JP - Giappone 4
IL - Israele 3
CA - Canada 1
DE - Germania 1
ES - Italia 1
HK - Hong Kong 1
IE - Irlanda 1
IN - India 1
IR - Iran 1
Totale 108
Città #
Ashburn 12
Rome 9
Shanghai 6
Singapore 5
Lawrence 4
Milan 4
Princeton 4
Cantù 3
Ibaraki 3
Kfar Saba 3
Boardman 2
Burolo 2
Chaoyang 2
New York 2
Washington 2
Central 1
Dublin 1
Ikoma 1
Kashan 1
Monza 1
Ottawa 1
Pune 1
Zaragoza 1
Totale 71
Nome #
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 29
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 23
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 16
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 14
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 14
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 11
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 9
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 2
Totale 118
Categoria #
all - tutte 1.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/202222 0 0 0 1 0 0 0 4 8 1 3 5
2022/202343 8 8 5 1 3 5 1 2 5 3 1 1
2023/202448 0 0 4 8 6 7 0 7 2 1 5 8
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 118